BDBM414516 N-(2-(4-(2-Hydroxypropan-2-yl)-5-methyloxazol-2-yl)ethyl)-N-methyl-2-(2H-1,2,3-triazol-2-yl)benzamide::US10435398, Example 30

SMILES CN(CCc1nc(c(C)o1)C(C)(C)O)C(=O)c1ccccc1-n1nccn1

InChI Key InChIKey=FGNHQRRBVKKBQO-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 414516   

TargetOrexin receptor type 2(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM414516(N-(2-(4-(2-Hydroxypropan-2-yl)-5-methyloxazol-2-yl...)
Affinity DataIC50: 390nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetOrexin/Hypocretin receptor type 1(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM414516(N-(2-(4-(2-Hydroxypropan-2-yl)-5-methyloxazol-2-yl...)
Affinity DataIC50: 1.00E+4nMAssay Description:In a typical experiment the OX1 and OX2 receptor antagonistic activity of the compounds of the present invention was determined in accordance with th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent